SCIENTURE HOLDINGS, INC. Payments for Software
SCIENTURE HOLDINGS, INC. (SCNX) reported Payments for Software of $138.88 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2024-08-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForSoftware · last filed 2024-08-09
- SCIENTURE HOLDINGS, INC. payments for software for the quarter ending 2023-06-30 was $51.80K.
- SCIENTURE HOLDINGS, INC. payments for software for the quarter ending 2023-03-31 was $87.07K.
- SCIENTURE HOLDINGS, INC. payments for software for the quarter ending 2022-12-31 was $114.94K.
- SCIENTURE HOLDINGS, INC. payments for software for the quarter ending 2022-09-30 was $55.73K.
- SCIENTURE HOLDINGS, INC. payments for software for fiscal 2022 was $450.85K.
| Period end | Payments for Software 3 month | Payments for Software 6 month | Payments for Software 9 month | Payments for Software 12 month |
|---|---|---|---|---|
| 2023-06-30 | $51.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $138.88K 10-Q · filed 2024-08-09 | $253.82K derived: sum of 3 quarters · filed 2024-08-09 | $309.55K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $87.07K 10-Q · filed 2023-05-15 | $202.01K derived: sum of 2 quarters · filed 2023-05-15 | $257.75K derived: sum of 3 quarters · filed 2024-01-16 | |
| 2022-12-31 | $114.94K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $170.67K derived: sum of 2 quarters · filed 2024-01-16 | $450.85K 10-K · filed 2023-03-27 | |
| 2022-09-30 | $55.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-16 | $335.90K 10-Q · filed 2024-01-16 | ||
| 2022-06-30 | $280.17K 10-Q · filed 2023-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |